Mechanisms of Paclitaxel-Induced Apoptosis in an Ovarian Cancer Cell Line and Its Paclitaxel-Resistant Clone

Publisher： Karger

E-ISSN： 1423-0232|66|1|53-61

ISSN： 0030-2414

Source： Oncology, Vol.66, Iss.1, 2004-03, pp. : 53-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topotecan and Gemcitabine in Platinum/Paclitaxel-Resistant Ovarian Cancer

By  

Oncology, Vol. 60, Iss. 1, 2000-12 ,pp. : 19-23

Karger

Access to resources Recommend Favorite

Paclitaxel-Induced Cell-Mediated Hypersensitivity Pneumonitis

By  

Oncology, Vol. 55, Iss. 4, 1998-06 ,pp. : 340-344

Karger

Access to resources Recommend Favorite

Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents

By  

Oncology, Vol. 84, Iss. 3, 2012-12 ,pp. : 158-165

Karger

Access to resources Recommend Favorite

Sequential Combination of Paclitaxel-Carboplatin and Paclitaxel-Liposomal Doxorubicin as a First-Line Treatment in Patients with Ovarian Cancer

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 348-353

Karger

Access to resources Recommend Favorite

Case of pure ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin but responsive to monotherapy with weekly irinotecan

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 5, 2015-05 ,pp. : 809-812

John Wiley & Sons Inc

Access to resources Recommend Favorite